CST3 and chronic kidney disease: However, the 2013 Kidney Disease Improving Global Outcomes (KDIGO) CKD Guideline Development Work Group suggests measuring cystatin C for confirmation of CKD only when markers of kidney damage are absent and eGFR by creatinine-based formulae is 45–59 mL/min per 1.73 m2 [13].